BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 23876845)

  • 1. Cytogenetics in the management of chronic lymphocytic leukemia: Guidelines from the Groupe Francophone de Cytogénétique Hématologique (GFCH).
    Nguyen-Khac F; Balogh Z; Chauzeix J; Veronese L; Chapiro E
    Curr Res Transl Med; 2023; 71(4):103410. PubMed ID: 38039634
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dic(17;18)(p11.2;p11.2) is a recurring abnormality in chronic lymphocytic leukaemia associated with aggressive disease.
    Woyach JA; Heerema NA; Zhao J; McFaddin A; Stark A; Lin TS; Andritsos LA; Blum KA; Flynn JM; Jones JA; Byrd JC
    Br J Haematol; 2010 Mar; 148(5):754-9. PubMed ID: 20015097
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Integrative genomic analysis implicates gain of PIK3CA at 3q26 and MYC at 8q24 in chronic lymphocytic leukemia.
    Brown JR; Hanna M; Tesar B; Werner L; Pochet N; Asara JM; Wang YE; Dal Cin P; Fernandes SM; Thompson C; Macconaill L; Wu CJ; Van de Peer Y; Correll M; Regev A; Neuberg D; Freedman AS
    Clin Cancer Res; 2012 Jul; 18(14):3791-802. PubMed ID: 22623730
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical and biological relevance of genomic heterogeneity in chronic lymphocytic leukemia.
    Friedman DR; Lucas JE; Weinberg JB
    PLoS One; 2013; 8(2):e57356. PubMed ID: 23468975
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of chronic lymphocytic leukemia by oligonucleotide-based microarray analysis uncovers novel aberrations not detected by FISH or cytogenetic analysis.
    Kolquist KA; Schultz RA; Slovak ML; McDaniel LD; Brown TC; Tubbs RR; Cook JR; Theil KS; Cawich V; Valentin C; Minier S; Neill NJ; Byerly S; Morton SA; Sahoo T; Ballif BC; Shaffer LG
    Mol Cytogenet; 2011 Nov; 4():25. PubMed ID: 22087757
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A cloud-based resource for genome coordinate-based exploration and large-scale analysis of chromosome aberrations and gene fusions in cancer.
    Wang J; Zheng J; Lee EE; Aguilar B; Phan J; Abdilleh K; Taylor RC; Longabaugh W; Johansson B; Mertens F; Mitelman F; Pot D; LaFramboise T
    Genes Chromosomes Cancer; 2023 Aug; 62(8):441-448. PubMed ID: 36695636
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Karyotype and outcome in CLL.
    Mulligan SP
    Blood; 2023 Aug; 142(5):402-404. PubMed ID: 37535371
    [No Abstract]   [Full Text] [Related]  

  • 8. Interstitial 13q14 deletions detected in the karyotype and translocations with concomitant deletion at 13q14 in chronic lymphocytic leukemia: different genetic mechanisms but equivalent poorer clinical outcome.
    Puiggros A; Venturas M; Salido M; Blanco G; Fernandez-Rodriguez C; Collado R; Valiente A; Ruiz-Xivillé N; Carrió A; Ortuño FJ; Luño E; Calasanz MJ; Ardanaz MT; Piñán MÁ; Talavera E; González MT; Ortega M; Marugán I; Ferrer A; Gimeno E; Bellosillo B; Delgado J; Hernández JÁ; Hernández-Rivas JM; Espinet B; ;
    Genes Chromosomes Cancer; 2014 Sep; 53(9):788-97. PubMed ID: 24915757
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Jumping translocations, a novel finding in chronic lymphocytic leukaemia.
    Miller CR; Stephens D; Ruppert AS; Racke F; McFaddin A; Breidenbach H; Lin HJ; Waller K; Bannerman T; Jones JA; Woyach JA; Andritsos LA; Maddocks K; Zhao W; Lozanski G; Flynn JM; Grever M; Byrd JC; Heerema NA
    Br J Haematol; 2015 Jul; 170(2):200-7. PubMed ID: 25891862
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chronic lymphocytic leukemia with a FGFR3 translocation: case report and literature review of an uncommon cytogenetic event.
    Geller MD; Pei Y; Spurgeon SE; Durum C; Leeborg NJ
    Cancer Genet; 2014; 207(7-8):340-3. PubMed ID: 25441688
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic abnormalities in chronic lymphocytic leukemia: where we are and where we go.
    Puiggros A; Blanco G; Espinet B
    Biomed Res Int; 2014; 2014():435983. PubMed ID: 24967369
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acquired chromosomal anomalies in chronic lymphocytic leukemia patients compared with more than 50,000 quasi-normal participants.
    Laurie CC; Laurie CA; Smoley SA; Carlson EE; Flinn I; Fridley BL; Greisman HA; Gribben JG; Jelinek DF; Nelson SC; Paietta E; Schaid D; Sun Z; Tallman MS; Weinshilboum R; Kay NE; Shanafelt TD
    Cancer Genet; 2014; 207(1-2):19-30. PubMed ID: 24613276
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chromosomal translocations and karyotype complexity in chronic lymphocytic leukemia: a systematic reappraisal of classic cytogenetic data.
    Baliakas P; Iskas M; Gardiner A; Davis Z; Plevova K; Nguyen-Khac F; Malcikova J; Anagnostopoulos A; Glide S; Mould S; Stepanovska K; Brejcha M; Belessi C; Davi F; Pospisilova S; Athanasiadou A; Stamatopoulos K; Oscier D
    Am J Hematol; 2014 Mar; 89(3):249-55. PubMed ID: 24166834
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combined somatic mutation and copy number analysis in the survival of familial CLL.
    Zhou W; Goldin L; Wang M; McMaster ML; Jones K; Burdett L; Chanock SJ; Yeager M; Dean M; Caporaso NE
    Br J Haematol; 2018 Jun; 181(5):604-613. PubMed ID: 29687880
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recurrent chromosome abnormalities define nonoverlapping unique subgroups of tumors in patients with chronic lymphocytic leukemia and known karyotypic abnormalities.
    Jimenez-Zepeda VH; Chng WJ; Schop RF; Braggio E; Leis JF; Kay N; Fonseca R
    Clin Lymphoma Myeloma Leuk; 2013 Aug; 13(4):467-76. PubMed ID: 23876845
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic subgroups in B-cell chronic lymphocytic leukemia defined by specific chromosomal abnormalities.
    Juliusson G; Oscier DG; Fitchett M; Ross FM; Stockdill G; Mackie MJ; Parker AC; Castoldi GL; Guneo A; Knuutila S; Elonen E; Gahrton G
    N Engl J Med; 1990 Sep; 323(11):720-4. PubMed ID: 2201915
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of trisomy 12, del(13q), del(17p), and del(11q) on the immunophenotype, DNA ploidy status, and proliferative rate of leukemic B-cells in chronic lymphocytic leukemia.
    Quijano S; López A; Rasillo A; Sayagués JM; Barrena S; Sánchez ML; Teodosio C; Giraldo P; Giralt M; Pérez MC; Romero M; Perdiguer L; Orfao A
    Cytometry B Clin Cytom; 2008 May; 74(3):139-49. PubMed ID: 18061951
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genomic abnormalities in chronic lymphocytic leukemia influence gene expression by a gene dosage effect.
    Dickinson JD; Joshi A; Iqbal J; Sanger W; Bierman PJ; Joshi SS
    Int J Mol Med; 2006 May; 17(5):769-78. PubMed ID: 16596259
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.